Interpace Diagnostics Group Inc (NASDAQ:IDXG)

1.05
Delayed Data
As of Feb 23
 0.00 / 0.00%
Today’s Change
0.72
Today|||52-Week Range
4.45
+2.94%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues150.8M119.9M9.4M13.1M
 
 
 
 
 
Cost of Goods Sold142.4M114.6M5.7M6.1M
 
 
 
 
 
Depreciation And Amortization1.4M2.4M5.0M4.3M
 
 
 
 
 
 
Operating ExpensesGross Income7.0M3.0M-1.3M2.7M
 
 
 
 
 
General Expenses11.3M14.3M27.7M17.6M
 
 
 
 
 
Research And Development----2.3M1.6M
 
 
 
Total Operating Expenses155.1M131.3M38.4M28.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.3M-11.4M-29.0M-14.9M
 
 
 
 
 
Extraordinary Credit0.00--8.0M11.9M
 
 
 
Extraordinary Charge0.00-2.1M-19.4M-3.4M
 
 
 
 
Interest Expense On Debt--602.0K3.7M2.1M
 
 
 
 
Other Expenses-59.0K-68.0K-93.0K14.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.3M-14.1M-44.2M-8.6M
 
 
 
 
 
Income Taxes-180.0K-4.7M-13.1M-162.0K
 
 
 
 
 
Discontinued Operations-49.0K-6.7M-1.9M-1.2M
 
 
 
 
 
Extraordinary Items0.000.0021.6M1.3M
 
 
 
Net Income-4.6M-16.1M-33.0M-9.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.5M1.5M1.5M1.8M
 
 
 
 
 
Shares To Calculate EPS Diluted1.5M1.5M1.5M1.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.10-$10.80-$7.30-$4.59
 
 
 
 
 
EPS Diluted-$3.10-$10.80-$21.32-$5.32